SignatureFD’s X4 Pharmaceuticals XFOR Stock Holding History

SignatureFD’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,996	Closed	-$8.24K	–	3648
2026 Q1	$8.24K	Sell	1,996 -758	-28%	-$2.84K	﹤0.01%	2591
2025 Q4	$11K	Buy	+2,754	New	+$10K	﹤0.01%	2388

Other funds holding XFOR

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SignatureFD's XFOR Position: Q2 2026 in Review

SignatureFD sold out of X4 Pharmaceuticals (XFOR) in Q2 2026, closing a stake of 1,996 shares — an estimated $8.24K sold.

SignatureFD first reported a position in XFOR in Q4 2025 and held it in 2 quarters. The position peaked at $11K in Q4 2025. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

SignatureFD reported no remaining X4 Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SignatureFD sold 1,996 X4 Pharmaceuticals shares in Q2 2026, an estimated $8.24K.
SignatureFD first reported a position in X4 Pharmaceuticals in Q4 2025 and held it in 2 quarters.
SignatureFD's X4 Pharmaceuticals position peaked at $11K in Q4 2025.
89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.